What is the role of [11C]choline PET/CT in decision making strategy before post-operative salvage radiation therapy in prostate cancer patients?

Acta Oncologica

Volumn 53, Issue 7, 2014, Pages 990-992

  Alongi, Filippo ^a   Comito, Tiziana ^a   Villa, Elisa ^a   Lopci, Egesta ^a   Cristina, Iftode ^a   Mancosu, Pietro ^a   Navarria, Pierina ^a   Liardo, Rocco Luca Emanuele ^a   Tomatis, Stefano ^a   Chiti, Arturo ^a   Scorsetti, Marta ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE C 11; PROSTATE SPECIFIC ANTIGEN; HORMONE; CARBON; CHOLINE;

CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL DECISION MAKING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONE BEAM COMPUTED TOMOGRAPHY; FOLLOW UP; HUMAN; LETTER; PATIENT POSITIONING; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RADIATION DOSE; SALVAGE THERAPY; ADULT; AGED; CANCER PATIENT; CLINICAL ARTICLE; LYMPH NODE DISSECTION; MALE; PATIENT DECISION MAKING; PELVIS LYMPH NODE; POSTOPERATIVE CARE; DECISION MAKING; DIAGNOSTIC USE; EVALUATION STUDY; MIDDLE AGED; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PROCEDURES; PROSTATIC NEOPLASMS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARBON RADIOISOTOPES; CHOLINE; DECISION MAKING; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PROSTATIC NEOPLASMS; SALVAGE THERAPY;

EID: 84903300636     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2013.865078     Document Type: Letter

References (10)

1. Pelosi E, Arena V, Skanjeti A, Pirro V, Douroukas A, Pupi A, et al. Role of whole-body 18F-choline PET/CT in disease detection in patients with biochemical relapse after radical treatment for prostate cancer . Radiol Med 2008; 113: 895-904.
2. Giovacchini G, Picchio M, Coradeschi E, Bettinardi V, Gianolli L, Scattoni V, et al. Predictive factors of [(11)C] choline PET/CT in patients with biochemical failure after radical prostatectomy . Eur J Nucl Med Mol Imaging 2010; 37: 301-9.
3. Mottet N, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, et al. EAU guidelines on prostate cancer . Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol 2011; 59: 572-83.
4. Alongi F, Fogliata A, Navarria P, Tozzi A, Mancosu P, Lobefalo F, et al. Moderate hypofractionation and simultaneous integrated boost with volumetric modulated arc therapy (RapidArc) for prostate cancer . Report of feasibility and acute toxicity. Strahlenther Onkol 2012; 188: 990-6.
5. Reske SN, Moritz S, Kull T. [11C]Choline-PET/CT for outcome prediction of salvage radiotherapy of local relapsing prostate carcinoma . Q J Nucl Med Mol Imaging 2012; 56: 430-9.
6. Souvatzoglou M, Krause BJ, Pürschel A, Thamm R, Schuster T, Buck AK, et al. Influence of 11C-choline PET/CT on the treatment planning for salvage radiation therapy in patients with biochemical recurrence of prostate cancer . Radiother Oncol 2011; 99: 193-200.
7. Würschmidt F, Petersen C, Wahl A, Dahle J, Kretschmer M . [18F]fluoroethylcholine-PET/CT imaging for radiation treatment planning of recurrent and primary prostate cancer with dose escalation to PET/CT-positive lymph nodes . Radiat Oncol 2011; 6: 44.
8. Stephenson AJ, Scardino P T, Kattan MW, Pisansky TM, Slawin KM, Klein EA, et al. Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy . J Clin Oncol 2007; 25: 2035-41.
9. Koppie TM, Grossfeld GD, Nudell DM, Weinberg VK, Carroll PR . Is anastomotic biopsy necessary before radiotherapy after radical prostatectomy? J Urol 2001; 166: 111-5.
10. Stephenson AJ, Shariat S F, Zelefsky M J, Kattan MW, Butler EB, Teh BS, et al. Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy . JAMA 2004; 291: 1325-32.